[Clinical research of HPV DNA detection and HPV RNA detection in single time].
OBJECTIVE
To research the application of the single time detection of HPV E6/E7 mRNA and HC2-HPV-DNA in cervical screening project.


METHODS
We detected both HPV E6/E7 mRNA and HC2-HPV-DNA of each sample which collected from 130 cervical disease patients' cervix during Jan. 2008 and July. 2009. TCT results were taken as standard to evaluate the diagnostic accuracy of the above two test methods in detecting high-grade cervical disease.


RESULTS
82.3% (107/130)women were confirmed to infect HPV by HC2-HPV-DNA detection, and 40.0% (52/130) women were confirmed to infect HPV by HPV E6/E7 mRNA detection, there was no significant difference between the two results (chi2 = 24.5, P < 0.05). The sensitivity, specificity, positive predictive value, negative predictive value of HC2-HPV-DNA detection were 90.1%, 22.1%, 37.4% and 82.6%, respectively. The sensitivity, specificity, positive predictive value, negative predictive value of HPV E6/E7 mRNA detection were 65.9%, 73.3%, 55.8% and 80.8%, respectively.


CONCLUSIONS
In clinical cervical screening project of single time, the combination of HC2-HPV-DNA detection and HPV E6/E7 mRNA detection wick take on more potential value than applying each of them alone. RNA;
Lu
Wen-bo
WB
Ningbo Women and Children's Hospital, Zhejiang 315012, China.
Jiang
Zhi-nan
ZN
Chen
Shun-mei
SM
Qin
Shi-rong
SR
Zhao
Lin-jun
LJ
Yang
Hai-tao
HT
Shi
Dan-hua
DH
Chen
Xue-mei
XM
D000328:Adult; D052685:Alphapapillomavirus / Q000235:genetics / Q000302:isolation & purification*; D004279:DNA, Viral / Q000235:genetics*; D005260:Female; D005821:Genetic Techniques; D006801:Humans; D008875:Middle Aged; D009856:Oncogene Proteins, Viral / Q000235:genetics; D030361:Papillomavirus Infections / Q000821:virology*; D012367:RNA, Viral / Q000235:genetics*; D014626:Vaginal Smears; D055815:Young Adult
D004279:DNA, Viral; D009856:Oncogene Proteins, Viral; D012367:RNA, Viral